U.S. Residential REITs Stock News

Rayonier Inc. recently revised its 2024 financial statements after selling its 77% stake in a New Zealand joint venture in June 2025, resulting in the reclassification of its New Zealand operations as discontinued and a realignment of its reportable segments. This move signals a shift in Rayonier’s business priorities and ensures adherence to SEC reporting standards amid evolving market strategies. We'll examine how the sale and segment restructuring may shift Rayonier's growth outlook and...

United Rentals (URI) just posted record third-quarter revenue and adjusted EBITDA, as demand from construction and industrial customers remained strong. The company also boosted its full-year financial outlook and announced an expanded $2 billion buyback. See our latest analysis for United Rentals. United Rentals’ latest strong quarter comes after a year of generally positive momentum. While the stock’s recent 1-month share price return of -11.2% signals short-term caution, its 2025 rally...

GlobalFoundries (GFS) has drawn increased attention from investors after unveiling a long-term strategic partnership with Navitas Semiconductor. This collaboration targets U.S.-based GaN design and manufacturing for high-power applications such as AI datacenters and energy infrastructure. See our latest analysis for GlobalFoundries. GlobalFoundries’ latest moves, including its GaN manufacturing alliance and new wins in aerospace chips, are stirring conversation, but the share price return...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Diversified Energy (NYSE:DEC) shares saw a slight uptick today, drawing attention from investors curious about the underlying drivers. With notable swings over the past month, there is interest in understanding what is impacting the stock’s recent performance. See our latest analysis for Diversified Energy. Diversified Energy’s 13% share price return over the past month suggests some renewed optimism, even though momentum has been mixed this year, with the stock still down 15% year-to-date...

Southwest Airlines (LUV) stock has seen some movement recently, and investors are sizing up what it means. While there has not been a major headline event driving the activity, ongoing sector dynamics have kept the shares on traders’ radar. See our latest analysis for Southwest Airlines. Southwest’s recent share price bump has caught the eye after a solid 7-day return of 4.49%, suggesting some renewed optimism even as the year-to-date share price return remains slightly negative. Over the...

Liquidia (LQDA) shares have been trending steadily higher over the past month, outpacing the broader biotech sector. The climb has caught the attention of investors who are looking for momentum plays in innovative healthcare names. See our latest analysis for Liquidia. Liquidia’s impressive move this past month, with a 33.5% share price return, builds on robust momentum that has been gathering steam all year. In fact, the company’s year-to-date share price return has surged 146.9%, and those...

Ever wondered if U.S. Bancorp's current share price actually gives you great value, or if it's already baked in by the market? You're not alone, and we're about to dig into what the numbers suggest. The stock has seen some interesting moves lately, up 5.0% over the last week but still just about flat for the year. This hints that investors are weighing both opportunity and risk. Banking stocks have been in the headlines recently as interest rate expectations shift and regulatory changes...

WellTheory recently announced a partnership with Instacart to give roughly 300,000 autoimmune care members access to Instacart Health Fresh Funds, enabling the purchase of clinically recommended groceries through Instacart’s nationwide network. This collaboration highlights Instacart’s increasing role in the food-as-medicine movement, extending its reach into virtual healthcare and addressing key barriers to nutritious food access for vulnerable populations. With Instacart’s Fresh Funds...

In the past week, multiple law firms announced class action lawsuits against Fortinet, alleging the company overstated its business performance and misrepresented the progress of its FortiGate firewall refresh cycle between November 2024 and August 2025. The news comes as Fortinet is also collaborating with Crime Stoppers International on a global Cybercrime Bounty program, further highlighting the company's public-private partnerships in the cybersecurity sector. We’ll explore how these...

Earlier this month, Nektar Therapeutics announced favorable new clinical data for its Phase 2b REZOLVE-AD study in atopic dermatitis and outlined an executive leadership transition, with Elizabeth Zhang set to become Chief Legal Officer at the end of December 2025. The company’s strengthened clinical pipeline and upcoming legal leadership change highlight its ongoing efforts to balance innovation with organizational continuity. We’ll explore how encouraging trial results for REZPEG could...

Lemonade (LMND) has piqued the interest of investors over the past month, with its stock climbing 40%, even in the absence of a specific catalyst. The company’s recent performance has many watching for signs of sustainable momentum. See our latest analysis for Lemonade. Lemonade’s 40% rally over the past month has grabbed attention, especially coming on the heels of a stellar year-to-date share price return of more than 100%. With a three-year total shareholder return of 285%, momentum...

Curious if GE HealthCare Technologies is more bargain or bubble at today’s price? You’re not alone, especially as investors look for real value in a complex market. GE HealthCare Technologies shares just jumped 10.8% over the past week, though the stock is still down 5.2% over the past year. This highlights both upside potential and wariness in the market. Recent headlines spotlight the company’s partnerships in digital health and AI-driven diagnostics, fueling excitement around its growth...

Rapport Therapeutics announced it will present new efficacy and safety data from its Phase 2a trial of RAP-219 in focal onset seizures at the 2025 American Epilepsy Society Annual Meeting in December, including detailed analysis on treatment effects and baseline disease severity. This upcoming scientific meeting offers the first in-depth look at RAP-219's potential impact in focal onset seizures, with multiple presentations and a dedicated exhibit planned to engage clinicians and...

In the past week, Alibaba Group Holding reported its second quarter and half-year earnings, alongside unveiling the rapid adoption of its newly revamped Qwen AI app, which surpassed 10 million downloads within its first week of public beta launch. This swift uptake of Qwen highlights Alibaba's efforts to unify and advance its AI offerings, signaling a broader intention to strengthen its position in China's competitive artificial intelligence sector. We'll explore how the rapid user growth of...

Artivion (AORT) just announced third-quarter results that outperformed expectations, and the company raised its full-year revenue and EBITDA guidance. Analysts responded by maintaining upbeat outlooks for the stock and citing strong operational momentum. See our latest analysis for Artivion. On the back of upbeat third-quarter results and growing operational confidence, Artivion’s share price has rallied, posting a striking 63.1% return so far this year. The company’s strong execution has...

NXP Semiconductors announced the board-approved payment of a US$1.014 per ordinary share interim dividend for Q4 2025, to be paid on January 7, 2026, reflecting confidence in its capital structure and outlook. This decision follows continued business strength and comes as the company pursues acquisitions in AI edge compute and automotive/industrial segments. We'll examine how the recent dividend affirmation and acquisition activity shape NXP's investment narrative amid upcoming earnings and...

BellRing Brands (NYSE:BRBR) just wrapped up its fiscal year with net sales rising 16% year over year, thanks in part to a renewed commercial push and its first media campaign since 2021. See our latest analysis for BellRing Brands. BellRing Brands’ recent earnings, share repurchase activity, and upbeat revenue guidance have helped fuel a turnaround in sentiment, with the stock rebounding sharply. Its 7-day share price return stands at 20.02% following a tough year, though its 1-year total...

Entergy (ETR) has recently caught some attention as investors take a closer look at the stock’s performance over the past year. Shares have climbed 29% in that time, which offers an interesting backdrop for anyone tracking the utility sector. See our latest analysis for Entergy. Momentum appears to be building for Entergy, with a strong climb over the past year reflected in a 28.75% total shareholder return and steady gains in recent months. While the utilities sector tends to move gradually,...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...

AIFU Inc. ( NASDAQ:AIFU ) shareholders that were waiting for something to happen have been dealt a blow with a 44...

Advanced Micro Devices (AMD) shares have caught the attention of investors recently, especially after the company’s performance over the past month and year. With recent market moves, there is renewed interest in AMD’s valuation and growth outlook. See our latest analysis for Advanced Micro Devices. AMD’s share price has certainly kept investors guessing, climbing more than 78% year-to-date and posting a 29% gain over the past 90 days. Recent volatility included a sharp one-day rise of 5.5%...

Lionsgate Studios (LION) shares have returned 10% in the past month, catching some interest in the media sector. Investors are watching closely to see whether recent momentum will continue, especially given the challenging year to date performance. See our latest analysis for Lionsgate Studios. Lionsgate Studios has seen a notable shift recently, with its share price rebounding 10.05% over the past month after a sluggish start to the year. While the year-to-date share price return is still...

Illumina, Inc. recently presented at the 7th Annual Wolfe Research Healthcare Conference in New York, where company leaders highlighted strategies to address challenges such as the Grail spin-off and ongoing policy changes. The company's foray into the spatial market with new technology has drawn both optimism and skepticism, reflecting broad interest and debate on Illumina's growth trajectory. We'll explore how renewed analyst sentiment following Illumina’s conference appearance may...